Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended November 30, 2023
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ____________ to ____________
Commission File Number: 001-35992
Oracle Corporation
(Exact name of registrant as specified in its charter)
Delaware
54-2185193
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
2300 Oracle Way
Austin, Texas
78741
(Address of principal executive offices)
(Zip Code)
(737) 867-1000
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.01 per share
3.125% senior notes due July 2025
ORCL
—
New York Stock Exchange
New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T ( 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
Accelerated filer
Non-accelerated filer
Smaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No
The number of shares of registrant’s common stock outstanding as of December 7, 2023 was: 2,748,922,000.
Table of Contents
ORACLE CORPORATION
FORM 10-Q QUARTERLY REPORT
TABLE OF CONTENTS
Page
PART I.
FINANCIAL INFORMATION
Item 1.
Financial Statements (Unaudited)
Condensed Consolidated Balance Sheets as of November 30, 2023 and May 31, 2023
Condensed Consolidated Statements of Operations for the Three and Six Months Ended November 30, 2023 and 2022
Condensed Consolidated Statements of Comprehensive Income for the Three and Six Months Ended November 30, 2023 and 2022
Condensed Consolidated Statements of Stockholders’ Equity (Deficit) for the Three and Six Months Ended November 30, 2023 and 2022
Condensed Consolidated Statements of Cash Flows for the Six Months Ended November 30, 2023 and 2022
Notes to Condensed Consolidated Financial Statements
Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
21
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
36
Item 4.
Controls and Procedures
36
PART II.
OTHER INFORMATION
37
Item 1.
Legal Proceedings
37
Item 1A.
Risk Factors
37
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
37
Item 5.
Other Information
38
Item 6.
Exhibits
39
Signatures
40
Table of Contents
Cautionary Note on Forward-Looking Statements
For purposes of this Quarterly Report on Form 10-Q (this Quarterly Report), the terms “Oracle,” “we,” “us” and “our” refer to Oracle Corporation and its consolidated subsidiaries. This Quarterly Report contains statements that are not historical in nature, are predictive in nature, or that depend upon or refer to future events or conditions or otherwise contain forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act), and Section 27A of the Securities Act of 1933, as amended (the Securities Act). These include, among other things, statements regarding:
•our expectation that we may acquire, and realize the anticipated benefits of acquiring, companies, products, services and technologies to further our corporate strategy as compelling opportunities become available;
•our expectation that, on a constant currency basis, our total cloud and license revenues generally will continue to increase due to expected growth in our cloud services and continued demand for our cloud license and on-premise license and license support offerings;
•our expectation that substantially all of our customers will renew their license support contracts upon expiration;
•our expectation that our hardware business will have lower operating margins as a percentage of revenues than our cloud and license business;
•our expectation that we will continue to make significant investments in research and development, and our belief that research and development efforts are essential to maintaining our competitive position;
•our expectation that our international operations will continue to provide a significant portion of our total revenues and expenses;
•our expectation that the proportion of our cloud services revenues relative to our total revenues will continue to increase;
•the sufficiency of our sources of funding for working capital, capital expenditures, contractual obligations, acquisitions, dividends, stock repurchases, debt repayments and other matters;
•our belief that we have adequately provided under U.S. generally accepted accounting principles for outcomes related to our tax audits, that the final outcome of our tax-related examinations, agreements or judicial proceedings will not have a material effect on our results of operations, and that our net deferred tax assets will likely be realized in the foreseeable future;
•our belief that the outcome of certain legal proceedings and claims to which we are a party will not, individually or in the aggregate, result in losses that are materially in excess of amounts already recognized, if any;
•the possibility that certain legal proceedings to which we are a party could have a material impact on our financial position or results of operations;
•the timing and amount of expenses we expect to incur;
•the cost savings we expect to realize pursuant to our Fiscal 2024 Oracle Restructuring Plan;
•declarations of future cash dividend payments and the timing and amount of future stock repurchases, including our expectation that the levels of our future stock repurchase activity may be modified in comparison to past periods in order to use available cash for other purposes;
Table of Contents
•our ability to predict revenues, particularly certain cloud license and on-premise license revenues and hardware revenues;
•the percentages of remaining performance obligations that we expect to recognize as revenues over respective future periods;
as well as other statements regarding our future operations, financial condition and prospects, and business strategies. Forward-looking statements may be preceded by, followed by or include the words “anticipates,” “believes,” “continues,” “could,” “endeavors,” “estimates,” “expects,” “intends,” “is designed to,” “may,” “plans,” “potential,” “seeks,” “should,” “strives,” “will” and similar expressions. We claim the protection of the safe harbor for forward-looking statements contained in the Exchange Act and the Securities Act for all forward-looking statements. We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to risks, uncertainties and assumptions about our business that could affect our future results and could cause those results or other outcomes to differ materially from those expressed or implied in the forward-looking statements. Factors that might cause or contribute to such differences include, but are not limited to, those discussed in “Risk Factors” included in documents we file from time to time with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-K for the fiscal year ended May 31, 2023 and our other Quarterly Reports on Form 10-Q to be filed by us in our fiscal 2024, which runs from June 1, 2023 to May 31, 2024.
We have no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or risks, except to the extent required by applicable securities laws. If we do update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements. New information, future events or risks could cause the forward-looking events we discuss in this Quarterly Report not to occur. You should not place undue reliance on these forward-looking statements, which reflect our expectations only as of the date of this Quarterly Report.
Table of Contents
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements (Unaudited)
ORACLE CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
As of November 30, 2023 and May 31, 2023
(Unaudited)
(in millions, except per share data)
November 30,
2023
May 31,
2023
ASSETS
Current assets:
Cash and cash equivalents
8,244
9,765
Marketable securities
446
422
Trade receivables, net of allowances for credit losses of $470 and $428 as of November 30, 2023 and May 31, 2023, respectively
6,804
6,915
Prepaid expenses and other current assets
3,795
3,902
Total current assets
19,289
21,004
Non-current assets:
Property, plant and equipment, net
18,009
17,069
Intangible assets, net
8,378
9,837
Goodwill, net
62,231
62,261
Deferred tax assets
12,758
12,226
Other non-current assets
13,659
11,987
Total non-current assets
115,035
113,380
Total assets
134,324
134,384
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Notes payable and other borrowings, current
6,321
4,061
Accounts payable
1,107
1,204
Accrued compensation and related benefits
1,706
2,053
Deferred revenues
8,878
8,970
Other current liabilities
6,395
6,802
Total current liabilities
24,407
23,090
Non-current liabilities:
Notes payable and other borrowings, non-current
82,468
86,420
Income taxes payable
10,046
11,077
Deferred tax liabilities
5,244
5,772
Other non-current liabilities
7,781
6,469
Total non-current liabilities
105,539
109,738
Commitments and contingencies
Oracle Corporation stockholders’ equity:
Preferred stock, $0.01 par value—authorized: 1.0 shares; outstanding: none
—
—
Common stock, $0.01 par value and additional paid in capital—authorized: 11,000 shares; outstanding: 2,748 shares and 2,713 shares as of November 30, 2023 and May 31, 2023, respectively
30,724
30,215
Accumulated deficit
(25,431
(27,620
Accumulated other comprehensive loss
(1,427
(1,522
Total Oracle Corporation stockholders’ equity
3,866
1,073
Noncontrolling interests
512
483
Total stockholders’ equity
4,378
1,556
Total liabilities and stockholders’ equity
134,324
134,384
See notes to condensed consolidated financial statements.
Table of Contents
ORACLE CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
For the Three and Six Months Ended November 30, 2023 and 2022
(Unaudited)
Three Months Ended
November 30,
Six Months Ended
November 30,
(in millions, except per share data)
2023
2022
2023
2022
Revenues:
Cloud services and license support
9,639
8,598
19,186
17,015
Cloud license and on-premise license
1,178
1,435
1,987
2,339
Hardware
756
850
1,470
1,613
Services
1,368
1,392
2,751
2,753
Total revenues
12,941
12,275
25,394
23,720
Operating expenses:
Cloud services and license support(1)
2,274
1,891
4,452
3,626
Hardware(1)
213
286
432
536
Services(1)
1,253
1,181
2,465
2,233
Sales and marketing(1)
2,093
2,216
4,118
4,393
Research and development
2,226
2,158
4,442
4,251
General and administrative
375
366
769
777
Amortization of intangible assets
755
907
1,518
1,826
Acquisition related and other
47
62
58
103
Restructuring
83
137
222
281
Total operating expenses
9,319
9,204
18,476
18,026
Operating income
3,622
3,071
6,918
5,694
Interest expense
(888
(856
(1,760
(1,643
Non-operating expenses, net
(14
(71
(63
(251
Income before income taxes
2,720
2,144
5,095
3,800
Provision for income taxes
217
403
172
511
Net income
2,503
1,741
4,923
3,289
Earnings per share:
Basic
0.91
0.65
1.80
1.22
Diluted
0.89
0.63
1.75
1.20
Weighted average common shares outstanding:
Basic
2,746
2,695
2,737
2,690
Diluted
2,817
2,746
2,820
2,747
(1)Exclusive of amortization of intangible assets, which is shown separately.
See notes to condensed consolidated financial statements.
Table of Contents
ORACLE CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
For the Three and Six Months Ended November 30, 2023 and 2022
(Unaudited)
Three Months Ended
November 30,
Six Months Ended
November 30,
(in millions)
2023
2022
2023
2022
Net income
2,503
1,741
4,923
3,289
Other comprehensive income (loss), net of tax:
Net foreign currency translation gains (losses)
86
95
42
(194
Net unrealized (losses) gains on cash flow hedges
(17
93
55
110
Other, net
—
(2
(1
Total other comprehensive income (loss), net
70
188
95
(85
Comprehensive income
2,573
1,929
5,018
3,204
See notes to condensed consolidated financial statements.
Table of Contents
ORACLE CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT)
For the Three and Six Months Ended November 30, 2023 and 2022
(Unaudited)
Three Months Ended
November 30,
Six Months Ended
November 30,
(in millions, except per share data)
2023
2022
2023
2022
Common stock and additional paid in capital
Balance, beginning of period
30,295
27,224
30,215
26,808
Common stock issued
118
146
426
661
Stock-based compensation
1,029
909
1,878
1,659
Repurchases of common stock
(43
(61
(56
(134
Shares repurchased for tax withholdings upon vesting of restricted stock-based awards
(673
(66
(1,733
(895
Other, net
(2
(4
(6
49
Balance, end of period
30,724
28,148
30,724
28,148
Accumulated deficit
Balance, beginning of period
(26,428
(31,134
(27,620
(31,336
Repurchases of common stock
(407
(361
(544
(847
Cash dividends declared
(1,099
(863
(2,190
(1,723
Net income
2,503
1,741
4,923
3,289
Balance, end of period
(25,431
(30,617
(25,431
(30,617
Other stockholders’ equity (deficit), net
Balance, beginning of period
(1,026
(1,539
(1,039
(1,240
Other comprehensive income (loss), net
70
188
95
(85
Other, net
41
44
29
18
Balance, end of period
(915
(1,307
(915
(1,307
Total stockholders’ equity (deficit)
4,378
(3,776
4,378
(3,776
Cash dividends declared per common share
0.40
0.32
0.80
0.64
See notes to condensed consolidated financial statements.
Table of Contents
ORACLE CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
For the Six Months Ended November 30, 2023 and 2022
(Unaudited)
Six Months Ended
November 30,
(in millions)
2023
2022
Cash flows from operating activities:
Net income
4,923
3,289
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation
1,510
1,138
Amortization of intangible assets
1,518
1,826
Deferred income taxes
(1,049
(852
Stock-based compensation
1,878
1,659
Other, net
331
289
Changes in operating assets and liabilities, net of effects from acquisitions:
Decrease in trade receivables, net
145
516
Decrease in prepaid expenses and other assets
301
121
Decrease in accounts payable and other liabilities
(1,048
(785
Decrease in income taxes payable
(1,541
(327
Increase in deferred revenues
149
369
Net cash provided by operating activities
7,117
7,243
Cash flows from investing activities:
Purchases of marketable securities and other investments
(515
(603
Proceeds from sales and maturities of marketable securities and other investments
157
462
Acquisitions, net of cash acquired
(59
(27,799
Capital expenditures
(2,394
(4,154
Net cash used for investing activities
(2,811
(32,094
Cash flows from financing activities:
Payments for repurchases of common stock
(600
(1,000
Proceeds from issuances of common stock
426
661
Shares repurchased for tax withholdings upon vesting of restricted stock-based awards
(1,733
(895
Payments of dividends to stockholders
(2,190
(1,723
Proceeds from issuances of commercial paper, net of repayments
1,749
1,880
Proceeds from issuances of senior notes and other borrowings, net of issuance costs
—
28,280
Repayments of senior notes and other borrowings
(3,500
(16,692
Other, net
31
(56
Net cash (used for) provided by financing activities
(5,817
10,455
Effect of exchange rate changes on cash and cash equivalents
(10
(174
Net decrease in cash and cash equivalents
(1,521
(14,570
Cash and cash equivalents at beginning of period
9,765
21,383
Cash and cash equivalents at end of period
8,244
6,813
Non-cash financing activities:
Fair values of stock awards assumed in connection with acquisitions
—
55
See notes to condensed consolidated financial statements.
Table of Contents
ORACLE CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
November 30, 2023
(Unaudited)
1.BASIS OF PRESENTATION, RECENT ACCOUNTING PRONOUNCEMENTS AND OTHER
Basis of Presentation
We have prepared the condensed consolidated financial statements included herein pursuant to the rules and regulations of the U.S. Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (GAAP) have been condensed or omitted pursuant to such rules and regulations. However, we believe that the disclosures herein are adequate to ensure the information presented is not misleading. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the notes thereto included in our Annual Report on Form 10-K for the fiscal year ended May 31, 2023.
We believe that all necessary adjustments, which consisted only of normal recurring items, have been included in the accompanying financial statements to present fairly the results of the interim periods. The results of operations for the interim periods presented are not necessarily indicative of the operating results to be expected for any subsequent interim period or for the fiscal year ending May 31, 2024.
During the first quarter of fiscal 2024, we finalized our adoption of Accounting Standards Update 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting and subsequent amendments to the initial guidance (collectively, Topic 848), which had no material impact to our current or historical condensed consolidated financial statements. There have been no changes to our significant accounting policies as disclosed in our Annual Report on Form 10-K for the fiscal year ended May 31, 2023 that had a significant impact on our condensed consolidated financial statements or notes thereto as of and for the six months ended November 30, 2023.
Cash, Cash Equivalents and Restricted Cash
Restricted cash that was included within cash and cash equivalents as presented within our condensed consolidated balance sheets as of November 30, 2023 and May 31, 2023 and our condensed consolidated statements of cash flows for the six months ended November 30, 2023 and 2022 was immaterial.
Remaining Performance Obligations from Contracts with Customers
Trade receivables, net of allowance for credit losses, and deferred revenues are reported net of related uncollected deferred revenues in our condensed consolidated balance sheets as of November 30, 2023 and May 31, 2023. The revenues recognized during the six months ended November 30, 2023 and 2022, respectively, that were included in the opening deferred revenues balances as of May 31, 2023 and 2022, respectively, were approximately $6.8 billion and $6.2 billion, respectively. Revenues recognized from performance obligations satisfied in prior periods and impairment losses recognized on our receivables were immaterial in each of the three and six months ended November 30, 2023 and 2022, respectively.
Remaining performance obligations, as defined in Note 1 of Notes to Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended May 31, 2023, were $65.5 billion as of November 30, 2023, approximately 48% of which we expect to recognize as revenues over the next twelve months, 35% over the subsequent month 13 to month 36 and the remainder thereafter.
Sales of Financing Receivables
We offer certain of our customers the option to acquire certain of our cloud and license, hardware and services offerings through separate long-term payment contracts. We generally sell these contracts that we have financed for our customers on a non-recourse basis to financial institutions within 90 days of the contracts’ dates of execution. We record the transfers of amounts due from customers to financial institutions as sales of financing receivables
Table of Contents
ORACLE CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
November 30, 2023
(Unaudited)
because we are considered to have surrendered control of these financing receivables. Financing receivables sold to financial institutions were $255 million and $816 million for the three and six months ended November 30, 2023, respectively, and $265 million and $1.2 billion for the three and six months ended November 30, 2022, respectively.
Non-Marketable Investments
Our non-marketable debt investments and equity securities and related instruments totaled $1.8 billion and $1.6 billion as of November 30, 2023 and May 31, 2023, respectively, and are included in other non-current assets in the accompanying condensed consolidated balance sheets and are subject to periodic impairment reviews. Certain of these non-marketable equity securities and related instruments are adjusted for observable price changes from orderly transactions. The majority of the non-marketable investments held as of these dates were with a related party entity for which we follow the equity method of accounting. We are also a counterparty to certain options to acquire additional equity interests in that entity at various times through June 2025 and we could obtain control of that entity should such options be exercised.
Acquisition Related and Other Expenses
Acquisition related and other expenses primarily consist of personnel related costs for transitional and certain other employees, certain business combination adjustments, including adjustments after the measurement period has ended, and certain other operating items, net.
Three Months Ended
November 30,
Six Months Ended
November 30,
(in millions)
2023
2022
2023
2022
Transitional and other employee related costs
21
12
38
Business combination adjustments, net
12
13
Other, net
29
38
33
57
Total acquisition related and other expenses
47
62
58
103
Non-Operating Expenses, net
Non-operating expenses, net consists primarily of interest income, net foreign currency exchange losses, the noncontrolling interests in the net profits of our majority-owned subsidiaries (primarily Oracle Financial Services Software Limited and Oracle Corporation Japan), net losses related to equity investments, including losses attributable to equity method investments and net other income and expenses, including net unrealized gains and losses from our investment portfolio related to our deferred compensation plan and non-service net periodic pension income and losses.
Three Months Ended
November 30,
Six Months Ended
November 30,
(in millions)
2023
2022
2023
2022
Interest income
133
52
269
90
Foreign currency losses, net
(32
(55
(113
(125
Noncontrolling interests in income
(41
(41
(78
(79
Losses from equity investments, net
(79
(40
(197
(126
Other income (expenses), net
13
56
(11
Total non-operating expenses, net
(14
(71
(63
(251
Table of Contents
ORACLE CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
November 30, 2023
(Unaudited)
Recent Accounting Pronouncements
Segment Reporting: In November 2023, the Financial Accounting Standards Board (FASB) issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (ASU 2023-07), which enhances the disclosures required for operating segments in our annual and interim consolidated financial statements. ASU 2023-07 is effective for us for our annual reporting for fiscal 2025 and for interim period reporting beginning in fiscal 2026 on a retrospective basis. Early adoption is permitted. We are currently evaluating the impact of our pending adoption of ASU 2023-07 on our consolidated financial statements.
2.ACQUISITIONS
Fiscal 2023 Acquisition of Cerner Corporation
On June 8, 2022, we completed our acquisition of Cerner Corporation (Cerner), a provider of digital information systems used within hospitals and health systems that are designed to enable medical professionals to deliver better healthcare to individual patients and communities.
The total purchase price for Cerner was $28.2 billion, which consisted of $28.2 billion in cash and $55 million for the fair values of restricted stock-based awards and stock options assumed. In allocating the purchase price based on estimated fair values, we recorded approximately $18.6 billion of goodwill, $12.0 billion of identifiable intangible assets and $2.4 billion of net tangible liabilities. See Note 2 of Notes to Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended May 31, 2023 for additional information regarding our acquisition of Cerner.
Other Fiscal 2024 and 2023 Acquisitions
During the first half of fiscal 2024 and full year fiscal 2023, we acquired certain other companies and purchased certain technology and development assets primarily to expand our products and services offerings. These acquisitions were not significant individually or in the aggregate to our condensed consolidated financial statements.
3.FAIR VALUE MEASUREMENTS
We perform fair value measurements in accordance with FASB Accounting Standards Codification (ASC) 820, Fair Value Measurement. ASC 820 defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required to be recorded at their fair values, we consider the principal or most advantageous market in which we would transact and consider assumptions that market participants would use when pricing the assets or liabilities, such as inherent risk, transfer restrictions and risk of nonperformance.
ASC 820 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. An asset’s or a liability’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 establishes three levels of inputs that may be used to measure fair value:
•Level 1: quoted prices in active markets for identical assets or liabilities;
•Level 2: inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices in active markets for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; or
•Level 3: unobservable inputs that are supported by little or no market activity and that are significant to the fair values of the assets or liabilities.
10
Table of Contents
ORACLE CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
November 30, 2023
(Unaudited)
Assets and Liabilities Measured at Fair Value on a Recurring Basis
Our assets and liabilities measured at fair value on a recurring basis consisted of the following (Level 1 and Level 2 inputs are defined above):